$2.05 Billion is the total value of Saratoga Research & Investment Management's 47 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 27.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UL | Buy | Unilever PLC | $124,122,045 | +7.2% | 2,512,592 | +13.1% | 6.06% | +13.5% |
| DIS | Buy | Disney Walt Co | $123,646,719 | +3.7% | 1,525,561 | +14.2% | 6.04% | +9.9% |
| RTX | Buy | RTX Corporation | $112,560,864 | -10.6% | 1,563,997 | +21.7% | 5.50% | -5.3% |
| MDT | Buy | Medtronic PLC | $101,741,684 | -2.0% | 1,298,388 | +10.2% | 4.97% | +3.8% |
| NVO | Buy | Novo Nordisk ADR | $80,951,605 | +9.3% | 890,165 | +94.5% | 3.95% | +15.8% |
| RHHBY | Buy | Roche Holding AG | $76,969,492 | +6.0% | 2,268,479 | +19.4% | 3.76% | +12.3% |
| NKE | Buy | NIKE | $64,694,102 | +11.4% | 676,575 | +28.6% | 3.16% | +18.0% |
| IFF | Buy | Int'l Flavors & Frag | $34,465,968 | -14.2% | 505,589 | +0.1% | 1.68% | -9.1% |
| MMM | Buy | 3M Company | $29,524,846 | +143.5% | 315,369 | +160.4% | 1.44% | +158.0% |
| CL | Buy | Colgate-Palmolive | $11,341,334 | -0.3% | 159,490 | +8.0% | 0.55% | +5.7% |
| AMGN | Buy | Amgen | $9,650,903 | +21.5% | 35,909 | +0.4% | 0.47% | +28.7% |
| SYY | New | Sysco Corp | $406,538 | – | 6,155 | +100.0% | 0.02% | – |
| JQUA | New | JP Morgan US Quality Factor ETetf | $222,970 | – | 5,153 | +100.0% | 0.01% | – |
| OKE | New | ONEOK Inc New | $202,849 | – | 3,198 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 42 | Q3 2023 | 7.3% |
| Oracle | 42 | Q3 2023 | 6.7% |
| Novo Nordisk ADR | 42 | Q3 2023 | 6.3% |
| Cisco Systems | 42 | Q3 2023 | 5.8% |
| C.H. Robinson Worldwide | 42 | Q3 2023 | 5.7% |
| WAL-MART STORES INC | 42 | Q3 2023 | 6.2% |
| Procter & Gamble | 42 | Q3 2023 | 4.4% |
| NIKE | 42 | Q3 2023 | 4.6% |
| JOHNSON & JOHNSON | 42 | Q3 2023 | 4.1% |
| Cognizant Tech Solutions | 42 | Q3 2023 | 4.7% |
View Saratoga Research & Investment Management's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-17 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-08-01 |
| 13F-HR | 2022-04-29 |
| 13F-HR | 2022-02-08 |
View Saratoga Research & Investment Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.